Clinical Trial

Role of Dexmedetomidine as Synergistic Agent

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated October 28, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to contribute valuable insights into the role of Dexmedetomidine as a synergistic agent in prolonging subarachnoid block duration, with the overarching goal of enhancing perioperative care and surgical success rates.
Trial Details
NCT Number NCT06662175
Lead Sponsor Lady Reading Hospital, Pakistan
Conditions Dexmedetomidine, Hyperbaric Bupivacaine, Subarachnoid Anesthesia
Enrollment 166 participants
Start Date 2024-11
Primary Completion 2025-07 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2024-10-28